Stryker Corporation - Asset Resilience Ratio
Stryker Corporation (SYK) has an Asset Resilience Ratio of 8.57% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2025)
This chart shows how Stryker Corporation's Asset Resilience Ratio has changed over time. Check SYK strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Stryker Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Stryker Corporation market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.01 Billion | 8.38% |
| Short-term Investments | $89.00 Million | 0.19% |
| Total Liquid Assets | $4.10 Billion | 8.57% |
Asset Resilience Insights
- Limited Liquidity: Stryker Corporation maintains only 8.57% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Stryker Corporation Industry Peers by Asset Resilience Ratio
Compare Stryker Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Stryker Corporation (1998–2025)
The table below shows the annual Asset Resilience Ratio data for Stryker Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.57% | $4.10 Billion | $47.84 Billion | -1.67pp |
| 2024-12-31 | 10.24% | $4.40 Billion | $42.97 Billion | +2.59pp |
| 2023-12-31 | 7.65% | $3.05 Billion | $39.91 Billion | +2.42pp |
| 2022-12-31 | 5.23% | $1.93 Billion | $36.88 Billion | -3.49pp |
| 2021-12-31 | 8.72% | $3.02 Billion | $34.63 Billion | -0.09pp |
| 2020-12-31 | 8.81% | $3.02 Billion | $34.33 Billion | -5.86pp |
| 2019-12-31 | 14.67% | $4.42 Billion | $30.17 Billion | +1.08pp |
| 2018-12-31 | 13.58% | $3.70 Billion | $27.23 Billion | +0.99pp |
| 2017-12-31 | 12.59% | $2.79 Billion | $22.18 Billion | -3.97pp |
| 2016-12-31 | 16.56% | $3.38 Billion | $20.43 Billion | +12.25pp |
| 2015-12-31 | 4.31% | $700.00 Million | $16.25 Billion | -13.79pp |
| 2014-12-31 | 18.09% | $3.21 Billion | $17.71 Billion | +1.32pp |
| 2013-12-31 | 16.78% | $2.64 Billion | $15.74 Billion | -4.68pp |
| 2012-12-31 | 21.46% | $2.89 Billion | $13.47 Billion | +1.20pp |
| 2011-12-31 | 20.26% | $2.51 Billion | $12.40 Billion | -3.81pp |
| 2010-12-31 | 24.07% | $2.62 Billion | $10.90 Billion | -1.24pp |
| 2009-12-31 | 25.31% | $2.30 Billion | $9.07 Billion | +5.66pp |
| 2008-12-31 | 19.66% | $1.49 Billion | $7.60 Billion | -9.18pp |
| 2007-12-31 | 28.83% | $2.12 Billion | $7.35 Billion | +11.84pp |
| 2006-12-31 | 16.99% | $998.20 Million | $5.87 Billion | +5.56pp |
| 2005-12-31 | 11.43% | $565.30 Million | $4.94 Billion | +11.30pp |
| 1999-12-31 | 0.14% | $3.50 Million | $2.58 Billion | -0.46pp |
| 1998-12-31 | 0.60% | $17.26 Million | $2.89 Billion | -- |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more